Pickup JC, Mattock MB, Chusney GD, Burt D: NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia. 1997, 40 (11): 1286-1292. 10.1007/s001250050822.
Article
CAS
PubMed
Google Scholar
Rizvi AA: Cytokine biomarkers, endothelial inflammation, and atherosclerosis in the metabolic syndrome: emerging concepts. Am J Med Sci. 2009, 338 (4): 310-318. 10.1097/MAJ.0b013e3181a4158c.
Article
PubMed
Google Scholar
Chu CS, Lee KT, Cheng KH, Lee MY, Kuo HF, Lin TH, Su HM, Voon WC, Sheu SH, Lai WT: Postchallenge responses of nitrotyrosine and TNF-alpha during 75-g oral glucose tolerance test are associated with the presence of coronary artery diseases in patients with prediabetes. Cardiovasc Diabetol. 2012, 11: 21-10.1186/1475-2840-11-21.
Article
PubMed Central
CAS
PubMed
Google Scholar
Jonasson L, Holm J, Skalli O, Bondjers G, Hansson GK: Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis. 1986, 6 (2): 131-138. 10.1161/01.ATV.6.2.131.
Article
CAS
PubMed
Google Scholar
Romagnani S: Th1/Th2 cells. Inflamm Bowel Dis. 1999, 5 (4): 285-294. 10.1097/00054725-199911000-00009.
Article
CAS
PubMed
Google Scholar
Miller AM: Role of IL-33 in inflammation and disease. J Inflamm (Lond). 2011, 8 (1): 22-10.1186/1476-9255-8-22.
Article
CAS
Google Scholar
Surendar J, Mohan V, Rao MM, Babu S, Aravindhan V: Increased levels of both Th1 and Th2 cytokines in subjects with metabolic syndrome (CURES-103). Diabetes Technol Ther. 2011, 13 (4): 477-482. 10.1089/dia.2010.0178.
Article
CAS
PubMed
Google Scholar
Gotsman I, Stabholz A, Planer D, Pugatsch T, Lapidus L, Novikov Y, Masrawa S, Soskolne A, Lotan C: Serum cytokine tumor necrosis factor-alpha and interleukin-6 associated with the severity of coronary artery disease: indicators of an active inflammatory burden?. Isr Med Assoc J. 2008, 10 (7): 494-498.
PubMed
Google Scholar
Dinh W, Futh R, Nickl W, Krahn T, Ellinghaus P, Scheffold T, Bansemir L, Bufe A, Barroso MC, Lankisch M: Elevated plasma levels of TNF-alpha and interleukin-6 in patients with diastolic dysfunction and glucose metabolism disorders. Cardiovasc Diabetol. 2009, 8: 58-10.1186/1475-2840-8-58.
Article
PubMed Central
PubMed
Google Scholar
Ofstad AP, Gullestad L, Orvik E, Aakhus S, Endresen K, Ueland T, Aukrust P, Fagerland MW, Birkeland KI, Johansen OE: Interleukin-6 and activin A are independently associated with cardiovascular events and mortality in type 2 diabetes: the prospective Asker and Baerum Cardiovascular Diabetes (ABCD) cohort study. Cardiovasc Diabetol. 2013, 12 (1): 126-10.1186/1475-2840-12-126.
Article
PubMed Central
PubMed
Google Scholar
Deepa M, Pradeepa R, Rema M, Mohan A, Deepa R, Shanthirani S, Mohan V: The Chennai Urban Rural Epidemiology Study (CURES)–study design and methodology (urban component) (CURES-I). J Assoc Physicians India. 2003, 51: 863-870.
CAS
PubMed
Google Scholar
Mohan V, Ravikumar R, Shanthi Rani S, Deepa R: Intimal medial thickness of the carotid artery in South Indian diabetic and non-diabetic subjects: the Chennai Urban Population Study (CUPS). Diabetologia. 2000, 43 (4): 494-499. 10.1007/s001250051334.
Article
CAS
PubMed
Google Scholar
Ravikumar R, Deepa R, Shanthirani C, Mohan V: Comparison of carotid intima-media thickness, arterial stiffness, and brachial artery flow mediated dilatation in diabetic and nondiabetic subjects (The Chennai Urban Population Study [CUPS-9]). Am J Cardiol. 2002, 90 (7): 702-707. 10.1016/S0002-9149(02)02593-6.
Article
PubMed
Google Scholar
Wilkinson IB, Fuchs SA, Jansen IM, Spratt JC, Murray GD, Cockcroft JR, Webb DJ: Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. J Hypertens. 1998, 16 (12 Pt 2): 2079-2084.
Article
CAS
PubMed
Google Scholar
Enas EA, Mehta J: Malignant coronary artery disease in young Asian Indians: thoughts on pathogenesis, prevention, and therapy. Coronary Artery Disease in Asian Indians (CADI) Study. Clin Cardiol. 1995, 18 (3): 131-135. 10.1002/clc.4960180305.
Article
CAS
PubMed
Google Scholar
Rana JS, Nieuwdorp M, Jukema JW, Kastelein JJ: Cardiovascular metabolic syndrome - an interplay of, obesity, inflammation, diabetes and coronary heart disease. Diabetes Obes Metab. 2007, 9 (3): 218-232. 10.1111/j.1463-1326.2006.00594.x.
Article
CAS
PubMed
Google Scholar
Frostegard J: Immune mechanisms in atherosclerosis, especially in diabetes type 2. Front Endocrinol (Lausanne). 2013, 4: 162.
Google Scholar
Rocha VZ, Folco EJ, Sukhova G, Shimizu K, Gotsman I, Vernon AH, Libby P: Interferon-gamma, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity. Circ Res. 2008, 103 (5): 467-476. 10.1161/CIRCRESAHA.108.177105.
Article
PubMed Central
CAS
PubMed
Google Scholar
Pacifico L, Di Renzo L, Anania C, Osborn JF, Ippoliti F, Schiavo E, Chiesa C: Increased T-helper interferon-gamma-secreting cells in obese children. Eur J Endocrinol. 2006, 154 (5): 691-697. 10.1530/eje.1.02138.
Article
CAS
PubMed
Google Scholar
Wegner M, Winiarska H, Bobkiewicz-Kozlowska T, Dworacka M: IL-12 serum levels in patients with type 2 diabetes treated with sulphonylureas. Cytokine. 2008, 42 (3): 312-316. 10.1016/j.cyto.2008.02.014.
Article
CAS
PubMed
Google Scholar
Jiang LQ, Franck N, Egan B, Sjogren RJ, Katayama M, Duque-Guimaraes D, Arner P, Zierath JR, Krook A: Autocrine role of interleukin-13 on skeletal muscle glucose metabolism in Type 2 diabetic patients involves microRNA let-7. Am J Physiol Endocrinol Metab. 2013, 305 (11): E1359-E1366. 10.1152/ajpendo.00236.2013.
Article
CAS
PubMed
Google Scholar
Chang YH, Ho KT, Lu SH, Huang CN, Shiau MY: Regulation of glucose/lipid metabolism and insulin sensitivity by interleukin-4. Int J Obes (Lond). 2011, 36 (7): 993-998.
Article
Google Scholar
Jonasson L, Holm J, Skalli O, Gabbiani G, Hansson GK: Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis. J Clin Invest. 1985, 76 (1): 125-131. 10.1172/JCI111934.
Article
PubMed Central
CAS
PubMed
Google Scholar
Frostegard J, Ulfgren AK, Nyberg P, Hedin U, Swedenborg J, Andersson U, Hansson GK: Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis. 1999, 145 (1): 33-43. 10.1016/S0021-9150(99)00011-8.
Article
CAS
PubMed
Google Scholar
Gupta S, Pablo AM, Jiang X, Wang N, Tall AR, Schindler C: IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. J Clin Invest. 1997, 99 (11): 2752-2761. 10.1172/JCI119465.
Article
PubMed Central
CAS
PubMed
Google Scholar
LaFramboise WA, Dhir R, Kelly LA, Petrosko P, Krill-Burger JM, Sciulli CM, Lyons-Weiler MA, Chandran UR, Lomakin A, Masterson RV: Serum protein profiles predict coronary artery disease in symptomatic patients referred for coronary angiography. BMC Med. 2012, 10: 157-10.1186/1741-7015-10-157.
Article
PubMed Central
CAS
PubMed
Google Scholar
Mallat Z, Taleb S, Ait-Oufella H, Tedgui A: The role of adaptive T cell immunity in atherosclerosis. J Lipid Res. 2009, 50 (Suppl): S364-S369.
PubMed Central
PubMed
Google Scholar
Fernandes JL, Mamoni RL, Orford JL, Garcia C, Selwyn AP, Coelho OR, Blotta MH: Increased Th1 activity in patients with coronary artery disease. Cytokine. 2004, 26 (3): 131-137. 10.1016/j.cyto.2004.01.007.
Article
CAS
PubMed
Google Scholar
Szodoray P, Timar O, Veres K, Der H, Szomjak E, Lakos G, Aleksza M, Nakken B, Szegedi G, Soltesz P: TH1/TH2 imbalance, measured by circulating and intracytoplasmic inflammatory cytokines–immunological alterations in acute coronary syndrome and stable coronary artery disease. Scand J Immunol. 2006, 64 (3): 336-344. 10.1111/j.1365-3083.2006.01816.x.
Article
CAS
PubMed
Google Scholar
Ishigami T, Abe K, Aoki I, Minegishi S, Ryo A, Matsunaga S, Matsuoka K, Takeda H, Sawasaki T, Umemura S: Anti-interleukin-5 and multiple autoantibodies are associated with human atherosclerotic diseases and serum interleukin-5 levels. ab. 2013, 27 (9): 3437-3445.
CAS
Google Scholar